SEC Filings

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML
10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML

Data provided by Kaleidoscope.